ARCHIVES

Critics of FDA misunderstand Bayesian analysis, statisticians say.

This article is from The Cancer Letter archive.

Vol. 31 No. 31 | August 5, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Advisory Group, Other Cancer Meetings

July 29, 1983

“Unfortunate Result Of Burzynski’s Practice Over Two Decades: Thousands Of Patients, Not Enough Data” To Determine Safety, Efficacy, FDA Says

September 25, 1998

Rep. Bruce Vento (D-MN) Has Cancer, Will Not Seek Re-Election.

February 4, 2000

What Would You Tell a 45-Year-Old? Waxman Asks Broder

February 4, 1994

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

July 26, 2013

ASCO Proposes Principles For Future Debate on Medicaid

November 21, 2014